FrancophonIA/ELRC3.0 huggingface dataset:
English: 100 mg chewable tablets: Each chewable tablet contains 100 mg of raltegravir (as potassium).
Maltese: Kull pillola fiha 100 mg ta' raltegravir (bħala potassju).
English: Give Isentress to your baby
Maltese: Ħallat Isentress u l-ilma
English: Isentress 25 mg chewable tablets Isentress 100 mg chewable tablets raltegravir
Maltese: Kull pillola li tomgħodha fiha 100 mg ta' raltegravir (bħala potassium).
English: In drug interaction studies, efavirenz did not have a clinically meaningful effect on the pharmacokinetics of raltegravir 1,200 mg once daily; therefore, other less potent inducers (e.g., efavirenz, nevirapine, rifabutin, glucocorticoids, St. John's wort, pioglitazone) may be used with the recommended dose of raltegravir.
Maltese: Fi studji dwar l-interazzjoni talmediċina, efavirenz ma kellux effett klinikament sinifikanti fuq il-farmakokinetiċi ta' raltegravir 1,200 mg darba kuljum; b'hekk provokaturi oħrajn inqas qawwijin (eż. efavirenz, nevirapine, rifabutin.
English: 3 x 100 mg twice daily The weight-based dosing recommendation for the chewable tablet is based on approximately 6 mg/kg/dose twice daily (see section 5.2).
Maltese: 3 x 100 mg darbtejn kuljum *Id-dożaġġ rakkomandat ibbażat fuq il-piż għall-pillola li tomgħodha huwa bbażat fuq madwar 6 mg/kg/doża darbtejn kuljum (see section 5.2).
English: Streptococcus pneumoniae saccharide suspension of: Serotype 4 2 µg
Maltese: Suspensjoni ta' streptococcus pneumoniae saccharide ta': Serotip 4 2 μg
English: 4 µg Conjugated to CRM197 carrier protein ~ 20 µg
Maltese: Konjugat għal CRM197 proteina carrier ~ 20 μg t x
English: 1 * A monodose preparation of 0.5 ml contains:
Maltese: 1 * Preparazzjoni ta' doża waħda ta' 0.5 ml fiha:
English: Serotype 18C 2 µg
Maltese: Serotip 18C 2 μg
English: 5 x 10 pre-filled syringes l t o r
Maltese: 5 x 10 siringi mimlijin għal-lest
English: Serotype 9V 2 µg
Maltese: Serotip 9V 2 μg
English: Serotype 14 2 µg
Maltese: Serotip 14 2 μg
English: Prevenar - Pharmaceutical Form(s) and Strength(s)
Maltese: Prevenar - Għamla(iet) Farmaċewtika(ċi) u Qawwa(iet)
English: Serotype 6B
Maltese: Serotip 6B 4 μg
English: 1 vial with 1 syringe and 2 needles
Maltese: 1 kunjett b'1 siringa u b'2 labriet
English: 1 pre-filled syringe with separate needle
Maltese: 1 siringa mimlija għallest b'labra separata
English: 10 pre-filled syringes with separate needles
Maltese: 10 siringi mimlijin għal-lest b'labar separati
English: Strength Pharmaceutical Form
Maltese: Kontenut Daqs tal-pakkett
English: ATC code: A10AB05.
Maltese: Kodiċi ATC A10AB05.
English: Date of last renewal: 30 April 2009
Maltese: Data ta' l-aħħar tiġdid: 30 t'April 2009
English: Absorption, distribution and elimination
Maltese: Assorbiment, distribuzzjoni u eliminazzjoni
English: See section 4.
Maltese: Ara sezzjon 4.
English: 0.03; 0.22] percentage points and by 0.15 [95% C.I.
Maltese: 12 [95% C.I. 0.03; 0.22] punt perċentwali u b'0.15 [95%
English: SAS, 45 Avenue d'Orléans F-28000 Chartres, France.
Maltese: SAS, 45, Avenue d'Orléans, F-28000 Chartres, Franza.
English: NovoRapid vial/NovoRapid Penfill/NovoRapid FlexPen/NovoRapid InnoLet/NovoRapid FlexTouch
Maltese: Il-kunjett NovoRapid/NovoRapid Penfill/NovoRapid FlexPen/NovoRapid InnoLet/NovoRapid FlexTouch
English: Oral antidiabetic medicinal products, monoamine oxidase inhibitors (MAOI), beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates, anabolic steroids and sulphonamides.
Maltese: Prodotti mediċinali orali kontra d-dijabete, inibituri ta' monoamine oxidase (MAOI), beta-blokkanti, inibituri ta' angiotensin converting enzyme (ACE), saliċilati, sterojdi anaboliċi u sulfonamidi.
English: NovoRapid Vial, InnoLet, FlexTouch and PumpCart:
Maltese: Kunjett NovoRapid, InnoLet, FlexTouch u PumpCart:
English: b) List of other side effects
Maltese: b) Lista ta' effetti sekondarji oħra
English: Multipack: 2 x (5 x 3 ml)
Maltese: 2 x (5 x 3 ml)..
English: Novo Nordisk A/S Hallas Allé DK-4400 Kalundborg Denmark
Maltese: Novo Nordisk A/S Hallas Allé DK-4400
English: For intravenous use, infusion systems with NovoRapid 100 units/ml at concentrations from 0.05 unit/ml to 1.0 unit/ml insulin aspart in the infusion fluids 0.9% sodium chloride, 5% dextrose or 10% dextrose including 40 mmol/l potassium chloride using polypropylene infusion bags, are stable at room temperature for 24 hours.
Maltese: Għall-użu minn ġol-vini, is-sistemi tal-infużjoni b'NovoRapid 100 unità/ml b'konċentrazzjonijiet minn 0.05 unitajiet/ml sa 1.0 unità/ml insulina aspart fil-fluwidi tal-infużjoni ta' 0.9% sodium chloride, 5% dextrose jew 10% dextrose inkluż 40 mmol/l potassium chloride meta jintużaw boroż talinfużjoni magħmula mill-polypropylene, huma stabbli f'temperatura ambjentali għal 24 siegħa.
English: c) Effects from diabetes
Maltese: ċ) Effetti tad-dijabete
English: • NovoRapid PumpCart contains 1.6 ml insulin aspart solution, equivalent to 160 units.
Maltese: • NovoRapid PumpCart fih 1.6 ml ta' soluzzjoni ta' insulin aspart, ekwivalenti għal 160 unità.
English: See c)
Maltese: Time (h)
English: The pharmacokinetic and pharmacodynamic properties of NovoRapid were investigated in children (6-12 years) and adolescents (13-17 years) with type 1 diabetes.
Maltese: Il-karatteristiċi farmakokinetiċi u farmakodinamiċi ta' NovoRapid ġew investigati fit-tfal (6 snin sa 12-il sena) u adolexxenti (13 sa 17-il sena) bid-dijabete tat-tip 1.
English: The absorption rate was somewhat slower in type 2 diabetic patients, resulting in a lower Cmax (352±240 pmol/l) and later tmax (60 (interquartile range: 50-90) minutes).
Maltese: Ir-rata ta' l-assorbiment kienet xi ftit aktar bilmod fil-pazjenti bid-dijabete tat-tip 2, li rriżulta f'Cmax aktar baxx (352±240 pmol/l) u ttardjar fit-tmax (60 (marġni interkwartili: 50-90) minuta) .
English: AUC, Cmax and CL/F were similar in patients with reduced hepatic function compared with subjects with normal hepatic function.
Maltese: L-AUC, is-Cmax, u s-CL/F kienu simili f'pazjenti b'tnaqqis fil-funzjoni epatika meta mqabbla ma' suġġetti b'funzjoni epatika normali.
English: The individual insulin requirement in adults and children is usually between 0.5 and 1.0 unit/kg/day.
Maltese: Il-ħtieġa individwali ta' l-insulina fl-adulti u fit-tfal hija normalment bejn 0.5 u 1.0 unitajiet/kg/jum.
English: • Bring NovoRapid PumpCart to room temperature.
Maltese: • Ġib NovoRapid PumpCart għat-temperatura tal-kamra.
English: However, Cmax differed between the age groups, stressing the importance of the individual titration of NovoRapid.
Maltese: Iżda, Cmax kien differenti bejn il-gruppi ta' etajiet, li jenfasizza l-importanza ta' dożaġġ individwali ta' NovoRapid.
English: Multipack: 5 packs of 1 x 10 ml vial
Maltese: Pakkett multiplu: 5 pakketti ta' kunjett 1 x 10 ml
English: The pharmacodynamic profile of insulin aspart in children was similar to that seen in adults.
Maltese: Il-profil farmakodinamiku ta' insulina aspart fit-tfal kien simili għal dak li kien osservat fl-adulti.
English: • If the second and third characters are S6, P5, K7, R7, VG, FG or ZF, the manufacturer is Novo
Maltese: • Jekk it-tieni u t-tielet karattri huma S6,P5,K7, R7, VG, FG jew ZF, il-manifattur huwa, Novo
English: 10 x 3 ml cartridges
Maltese: 10 x 3 ml skrataċ
English: NovoRapid Penfill and FlexPen:
Maltese: NovoRapid Penfill u FlexPen:
English: 0.26] percentage points compared to human insulin; a difference of limited clinical significance.
Maltese: C.I. 0.05; 0.26] punt perċentwali meta mqabbel ma' insulina umana; differenza li s-sinifikat kliniku tagħha hija limitata.
English: 10 ml 1 vial of 10 ml contains 1,000 units
Maltese: 10 ml Kunjett ta' 10 ml fih 1,000 unità
English: PumpCart - with blue box)
Maltese: PumpCart- bil-kaxxa blu)
English: • Sympathomimetics (such as epinephrine [adrenaline], or salbutamol, terbutaline used to treat asthma)
Maltese: • Simpatomimetiċi ( bħal epinephrine [adrenaline] jew salbutamol, terbutaline użati fil-kura talażma)
English: NovoRapid 100 units/ml solution for injection in vial NovoRapid Penfill 100 units/ml solution for injection in cartridge NovoRapid FlexPen 100 units/ml solution for injection in pre-filled pen NovoRapid InnoLet 100 units/ml solution for injection in pre-filled pen NovoRapid FlexTouch 100 units/ml solution for injection in pre-filled pen NovoRapid PumpCart 100 units/ml solution for injection in cartridge
Maltese: NovoRapid 100 unità/ml soluzzjoni għall-injezzjoni f'kunjett NovoRapid Penfill 100 unità/ml soluzzjoni għall-injezzjoni fi skartoċċ NovoRapid FlexPen 100 unità/ml soluzzjoni għall-injezzjoni f'pinna mimlija għal-lest NovoRapid InnoLet 100 unità/ml soluzzjoni għall-injezzjoni f'pinna mimlija għal-lest NovoRapid FlexTouch 100 unità/ml soluzzjoni għall-injezzjoni f'pinna mimlija għal-lest NovoRapid PumpCart 100 unità/ml soluzzjoni għall-injezzjoni fi skartoċċ
English: The trials included 167 children aged 1-5 years, 260 aged 6-11 and 285 aged 12-17.
Maltese: Il-provi inkludew 167 tifel u tifla b'etajiet minn 1-5 snin, 260 b'etajiet minn 6-11 u 285 b'etajiet minn
English: NovoRapid vial/NovoRapid Penfill
Maltese: Il-kunjett NovoRapid/NovoRapid Penfill
English: In addition the data from a clinical trial including 27 women with gestational diabetes randomised to treatment with insulin aspart vs. human insulin (insulin aspart: 14; human insulin: 13) showed similar safety profiles between treatments.
Maltese: Barra minn hekk, ir-riżultati minn studju kliniku li kien jinkludi 27 mara li kellhom id-dijabete waqt ittqala u li b'mod arbitrarju ngħataw trattament b'insulina aspart jew b'insulina umana (insulina aspart: 14; insulina umana: 13) urew profili ta' sigurtà simili bejn it-trattamenti.
English: *Insulin aspart is produced in Saccharomyces cerevisiae by recombinant DNA technology.
Maltese: *Insulina aspart hu magħmul fis-Saccharomyces cerevisiae permezz tat-teknoloġija tad-DNA rikombinanti.
English: Insulin aspart was rapidly absorbed in both age groups, with similar tmax as in adults.
Maltese: Insulina aspart ġie assorbit malajr fiżżewġ gruppi ta' etajiet, b'tmax simili għal dak ta' l-adulti.
English: Modern insulin products are improved versions of human insulin.
Maltese: Prodotti moderni talinsulina huma verżjonijiet imtejba tal-insulina umana.
English: The relative differences in the pharmacodynamic properties (GIRmax,AUCGIR, 0-120 min) between insulin aspart and soluble human insulin in the elderly were similar to those seen in healthy subjects and in younger patients with diabetes.
Maltese: Id-differenzi relattivi fil-karatteristiċi farmakodinamiċi (GIRmax, AUCGIR, 0-120 min) bejn insulina aspart u insulina umana li tinħall fl-anzjani kienu simili għal dawk li kien hemm f'suġġetti b'saħħithom u f'pazjenti iżgħar bid-dijabete
English: • Sulphonamides (used to treat infections).
Maltese: • Sulphonamides (użati fil-kura ta' infezzjonijiet)
English: Pioglitazone (tablets used for the treatment of type 2 diabetes)
Maltese: Pioglitazone (pilloli użati fil-kura tad-dijabete mellitus tat-tip 2)
English: Pack size of 5 cartridges and a multipack containing 25 (5 packs of 5) cartridges of 1.6 ml.
Maltese: Daqs ta' pakkett ta' 5 skrataċ u pakkett multiplu li fih 25 skartoċċ (5 pakketti ta' 5) ta' 1.6 ml.
English: 5 x 1.6 ml cartridges.
Maltese: 5 skrataċ x 1.6 ml.
English: Always mix NovoRapid and the NPH insulin in the same sequence.
Maltese: Dejjem ħallat NovoRapid u l-insulina NPH fl-istess sekwenza.
English: Insulin window
Maltese: Insulina aspart
English: Substances added to NovoRapid may cause degradation of insulin aspart.
Maltese: Sustanzi miżjuda ma' NovoRapid jistgħu jikkawżaw id-degradazzjoni ta' insulina aspart.
English: 1 vial of 10 ml.
Maltese: Kunjett 1 ta' 10 ml.
English: • Drink alcohol (see Drinking alcohol and taking NovoRapid in section 2).
Maltese: • Tixrob l-alkoħol (ara Tixrob l-alkoħol u tieħu NovoRapid f'sezzjoni 2)
English: A decreased absorption rate was observed in elderly patients, resulting in a later tmax (82 (interquartile range: 60-120) minutes), whereas Cmax was similar to that observed in younger patients with type 2 diabetes and slightly lower than in patients with type 1 diabetes.
Maltese: Ġie osservat tnaqqis fir-rata ta' assorbiment f'pazjenti anzjani, li rriżulta f'tmax itwal (82 (marġni interkwartili: 60-120) minuta), filwaqt li s-Cmax kien simili għal dak osservat f'pazjenti iżgħar bid-dijabete tat-tip 2 u ftit inqas minn dak ta' pazjenti bid-dijabete tat-tip 1.
English: 1 vial contains 10 ml equivalent to 1,000 units.
Maltese: Kunjett NovoRapid Kunjett wieħed fih 10 ml ekwivalenti għal 1,000 unità.
English: EU/1/99/119/019 1 pen of 3 ml EU/1/99/119/020 5 pens of 3 ml EU/1/99/119/022 1 pen of 3 ml and 7 NovoFine needles EU/1/99/119/023 1 pen of 3 ml and 7 NovoTwist needles
Maltese: EU/1/99/119/020 5 pinen ta' 3 ml EU/1/99/119/022 pinna ta' 3 ml u 7 labar NovoFine EU/1/99/119/023 pinna ta' 3 ml u 7 labar NovoTwist
English: If it shows 80, at least 80 units are left in your pen.
Maltese: Jekk juri 80, għad fadal mill inqas 80 unità fil-pinna tiegħek.
English: 1 cartridge contains 3 ml equivalent to 300 units.
Maltese: Skartoċċ fih 3 ml ekwivalenti għal 300 unità.
English: Uncommon - Urticaria, rash, eruptions Very rare - Anaphylactic reactions*
Maltese: Mhux komuni - Urtikarja, raxx, eruzzjonijiet Rari ħafna - Reazzjonijiet anafilattiċi*
English: EU/1/99/119/011 1 pen of 3 ml EU/1/99/119/009 5 pens of 3 ml EU/1/99/119/010 10 pens of 3 ml EU/1/99/119/017 1 pen of 3 ml and 7 NovoFine needles EU/1/99/119/018 1 pen of 3 ml and 7 NovoTwist needles
Maltese: EU/1/99/119/011 pinna ta' 3 ml EU/1/99/119/009 5 pinen ta' 3 ml EU/1/99/119/010 10 pinen ta' 3 ml EU/1/99/119/017 pinna ta' 3 ml u 7 labar NovoFine
English: NovoRapid FlexTouch contains 300 units of insulin and delivers doses from 1 to 80 units, in increments of 1 unit.
Maltese: FlexTouch fiha 300 unità ta' insulina u tagħti dożi minn 1 sa 80 unità, f'inkrementi ta' unità 1.
English: NovoRapid®
Maltese: NovoRapid® FlexTouch®
English: In NovoRapid substitution of amino acid proline with aspartic acid at position B28 reduces the tendency to form hexamers as observed with soluble human insulin.
Maltese: F'NovoRapid, is-sostituzzjoni ta' l-amino-aċidu proline b'aspartic acid fil-pożizzjoni B28 tnaqqas ittendenza li jiġu ffurmati hexamers kif tabilħaqq jiġri bl-insulina umana solubbli.
English: • Thyroid hormones (used to treat thyroid gland disorders)
Maltese: • Ormoni tat-tirojde ( użati fil-kura ta' disturbi fil-glandola tat-tirojde)
English: Uncommon - Refraction disorders Uncommon - Diabetic retinopathy
Maltese: Mhux komuni - Retinopatija dijabetika
English: A clinical trial comparing safety and efficacy of insulin aspart vs. human insulin in the treatment of pregnant women with type 1 diabetes (322 exposed pregnancies (insulin aspart: 157; human insulin: 165)) did not indicate any adverse effect of insulin aspart on pregnancy or on the health of the foetus/newborn.
Maltese: Studju kliniku li qabbel is-sigurtà u l-effikaċja ta' insulina aspart ma' dawk ta' l-insulina umana fil kura ta' nisa tqal li kellhom dijabete ta' tip 1 (322 nisa tqal li kienu esposti (insulina aspart: 157;
English: Rare - Peripheral neuropathy (painful neuropathy)
Maltese: Rari - Newropatija periferali (newropatija bl uġigħ)
English: See c) Effects from diabetes in section 4.
Maltese: Ara ċ) Effetti tad-dijabete f'sezzjoni 4.
English: 1 cartridge contains 1.6 ml equivalent to 160 units.
Maltese: NovoRapid PumpCart Skartoċċ wieħed fih 1.6 ml ekwivalenti għal 160 unità.
English: NovoRapid may be used in an infusion pump system (CSII) as described in section 4.2.
Maltese: NovoRapid jista' jintuża f'sistema ta' pompi tal-infużjoni (CSII) kif deskritt fis-sezzjoni 4.2.
English: The relative differences in pharmacokinetic properties between insulin aspart and soluble human insulin in elderly patients (65-83 years, mean age 70 years) with type 2 diabetes were similar to those observed in healthy subjects and in younger patients with diabetes.
Maltese: Id-differenzi relattivi fil-karatteristiċi farmakokinetiċi bejn insulina aspart u insulina umana solubbli f'pazjenti anzjani (65 sa 83 sena, età medja 70 sena) bid-dijabete tat-tip 2 kienu simili għal dawk li kien hemm f'suġġetti b'saħħithom u f'pazjenti iżgħar bid-dijabete.
English: INFORMATION IN BRAILLE NovoRapid
Maltese: INFORMAZZJONI BIL-BRAILLE
English: Animal reproduction studies have not revealed any differences between insulin aspart and human insulin regarding fertility.
Maltese: Studji fuq ir-riproduzzjoni fl-annimali ma wrew ebda differenza bejn insulina aspart u l-insulina umana fir-rigward tal-fertilità.
English: Can be stored in a refrigerator (2˚C to 8˚C)
Maltese: Aħżen fi friġġ (2°C sa 8°C)
English: • If the second and third characters are H7 or T6, the manufacturer is Novo Nordisk Production
Maltese: • Jekk it-tieni u t-tielet karattri huma H7 jew T6, il-manifattur huwa, Novo Nordisk Production
English: The duration of action is 3 to 5 hours.
Maltese: Idum jaħdem bejn 3 sa 5 sigħat.
English: This may reduce the risk of developing lumps or skin pitting (see section 4, Possible side effects).
Maltese: Dan jista' jnaqqas ir-riskju li tiżviluppa nefħiet jew il-ġilda titħaffer ( ara sezzjoni 4, Effetti sekondarji possibbli).
English: A randomised, double-blind cross-over PK/PD trial comparing insulin aspart with soluble human insulin was performed in elderly patients with type 2 diabetes (19 patients aged 65-83 years, mean age 70 years).
Maltese: Studju farmakokinetiku/farmakodinamiku cross-over,double-blind u magħmul b'mod arbitrarju kkompara insulina aspart ma' insulina umana solubbli f'pazjenti anzjani bid-dijabete tat-tip 2 (19-il pazjent b'etajiet bejn 65-83 sena, età medja ta' 70 sena).
English: You can select doses from 1 to 60 units in increments of 1 unit.
Maltese: tisselezzjona dożi minn 1 sa 60 unità f'inkrementi ta' unità 1.
English: If you stop the pump, the insulin effect will last for 3 to 5 hours.
Maltese: Jekk twaqqaf il-pompa, l-effett tal-insulina se jibqa' għal 3 sa 5 sigħat.
English: In patients with hepatic impairment, absorption rate was decreased and more variable, resulting in delayed tmax from about 50 min in subjects with normal hepatic function to about 85 min in patients with moderate and severe hepatic impairment.
Maltese: f'suġġetti b'funzjoni epatika normali għal madwar 85 min f'pazjenti b'indeboliment epatiku moderat u sever.
English: The efficacy and safety of NovoRapid given as bolus insulin in combination with either insulin detemir or insulin degludec as basal insulin has been studied for up to 12 months, in two randomised controlled clinical trials in adolescents and children aged 1 to less than 18 years (n=712).
Maltese: L-effikaċja u s-sigurtà ta' NovoRapid mogħti bħala insulina bolus flimkien ma' jew insulina detemir jew insulina degludec bħala insulina bażali ġew studjati sa 12-il xahar f'żewġ provi kliniċi kkontrollati u magħmula b'mod arbitrarju f'adolexxenti u tfal mill-età ta' sena sa inqas minn 18-il sena (n=712).
English: A single dose pharmacokinetic study of insulin aspart in 18 subjects with renal function ranging from normal to severely impaired was performed.
Maltese: Studju farmakokinetiku b'doża waħda ta' insulina aspart ġie magħmul f'18-il suġġett b'funzjoni renali li tvarja minn normali għal indeboliment sever.
English: BATCH NUMBER Batch:
Maltese: NUMRU TAL- LOTT Lott:
English: 2 units selected
Maltese: Intgħażlu 2 unitajiet
English: Uncommon - Lipodystrophy*
Maltese: Komuni ħafna - Ipogliċemija*
English: Other medicines and NovoRapid
Maltese: Mediċini oħra u NovoRapid
English: High blood sugar (hyperglycaemia)
Maltese: Blood glucose (mmol/l)
English: NovoRapid Penfill EU/1/99/119/003 EU/1/99/119/006
Maltese: EU/1/99/119/003 EU/1/99/119/006
English: 5 x 3 ml pre-filled pens 1 x 3 ml pre-filled pen + 7 NovoFine needles 1 x 3 ml pre-filled pen + 7 NovoTwist needles
Maltese: 1 x 3 ml pinna mimlija għal-lest+ 7 labar NovoFine 1 x 3 ml pinna mimlija għal-lest+ 7 labar NovoTwist
English: 1 ml solution contains 100 units insulin aspart (equivalent to 3.5 mg),
Maltese: Millilitru ta' soluzzjoni fih 100 unità insulina aspart* (ekwivalenti għal 3.5 mg).
English: Each ml contains 100 units of insulin aspart.
Maltese: Millilitru fih 100 unità ta' insulina aspart.
English: Novo Nordisk Production SAS 45, Avenue d'Orléans F-28000 Chartres France
Maltese: 45, Avenue d'Orléans
English: ► NovoRapid Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles.
Maltese: ► L-iskrataċ ta' NovoRapid Penfill huma magħmula biex jintużaw mas-sistemi tal-għoti tal insulina Novo Nordisk u mal-labar NovoFine jew NovoTwist.
English: NPH (Neutral Protamine Hagedorn) insulin is the only type of insulin that can be mixed with NovoRapid and the mixture must be injected immediately under your skin (subcutaneously).
Maltese: L-insulina NPH (Neutral Protamine Hagedorn) hija l-unika insulina li tista' titħallat ma' NovoRapid u t-taħlita għandha tiġi injettata mill-ewwel taħt il-ġilda tiegħek (b'mod subkutaneju).
English: White label band
Maltese: Kompartiment għall-labar
English: Pack sizes of 1 or 5 vials of 10 ml or a multipack of 5 packs of 1 x 10 ml vial.
Maltese: Daqsijiet ta' pakketti ta' 1 jew 5 kunjetti ta' 10 ml jew pakkett multiplu ta' 5 pakketti ta' kunjett 1 x 10 ml.
English: MARKETING AUTHORISATION NUMBERS EU/1/99/119/001 1 vial of 10 ml EU/1/99/119/008 5 vials of 10 ml
Maltese: EU/1/99/119/001 Kunjett ta' 10 ml EU/1/99/119/008 5 kunjetti ta' 10 ml
English: NovoRapid FlexPen/NovoRapid InnoLet/NovoRapid FlexTouch 1 pre-filled pen contains 3 ml equivalent to 300 units.1 ml solution contains 100 units insulin aspart* (equivalent to 3.5 mg).
Maltese: DIKJARAZZJONI TAS-SUSTANZA ATTIVA Pinna mimlija għal-lest fiha 3 ml ekwivalenti għal 300 unità, Millilitru ta' soluzzjoni fih 100 unità insulina aspart (ekwivalenti għal 3.5 mg).
English: 10 ml solution in vial (type 1 glass) closed with a disc (bromobutyl/polyisoprene rubber) and a protective tamper-proof plastic cap.
Maltese: Il-kunjett NovoRapid Soluzzjoni ta' 10 ml f'kunjett (tal-ħġieġ tat-tip 1) magħluq b'diska (gomma tal bromobutyl/polyisoprene) u għatu protettiv tal-plastik li jingħalaq b'sikurezza.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAPPER LABEL ON MULTIPACK (VIAL - with blue box)
Maltese: KARTUNA TA' ĠEWWA GĦALL-PAKKETT MULTIPLU (KUNJETT - mingħajr il-kaxxa blu)
English: NovoRapid contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoRapid is essentially ‘sodiumfree'.
Maltese: NovoRapid fih inqas minn mmol 1 ta' sodium (23 mg) għal kull doża, i.e tista tgħid li NovoRapid huwa ‘bla sodium'.
English: INFORMATION IN BRAILLE NovoRapid Penfill
Maltese: Ara wkoll sezzjoni 6.2. NovoRapid Penfill
English: Pack sizes of 1, 5 and 10 pre-filled pens of 3 ml.
Maltese: Daqsijiet ta' pakketti ta' 1, 5 u 10 pinen mimlijin għal-lest ta' 3 ml.
English: LIST OF EXCIPIENTS glycerol, phenol, metacresol, zinc chloride, disodium phosphate dihydrate, sodium chloride, hydrochloric acid/sodium hydroxide for pH adjustment and water for injections
Maltese: TA' EĊĊIPJENTI glycerol, phenol, metacresol, zinc chloride,disodium phosphate dihydrate,sodium chloride, hydrochloric acid / sodium hydroxide għall-aġġustament fil-pH u ilma għall-injezzjonijiet
English: Other medicines and NovoRapid PumpCart
Maltese: Mediċini oħra u NovoRapid PumpCart
English: NovoRapid vial/NovoRapid PumpCart
Maltese: L-użu ħażin ta' NovoRapid PumpCart
English: A single dose pharmacokinetic study of insulin aspart was performed in 24 subjects with hepatic function ranging from normal to severely impaired.
Maltese: Studju farmakokinetiku b'doża waħda ta' insulina aspart ġie magħmul f'24 suġġett b'funzjoni epatika li tvarja minn normali għal indeboliment sever.
English: people.
Maltese: INDIVIDWALI.
English: NovoRapid PumpCart carried as a spare can be kept for up to 2 weeks below 30°C.
Maltese: NovoRapid PumpCart li jkun qed jinġarr għal li jista' jinqala' jista' jinżamm sa ġimgħatejn taħt 30°C.
English: During use: Store below 30°C.
Maltese: Aħażen f'temperatura taħt 30°C.
English: 1 vial contains 10 ml equivalent to 1,000 units.1 ml solution contains 100 units insulin aspart* (equivalent to 3.5 mg).
Maltese: Kunjett fih 10 ml ekwivalenti għal 1,000 unità, Millilitru ta' soluzzjoni fih 100 unità insulina aspart(ekwivalenti għal 3.5 mg).